Erythropoietin is neuroprotective on GABAergic neurons against kainic acid-excitotoxicity in the rat spinal cell cultures

Brain Research

Volumn 1154, Issue 1, 2007, Pages 31-39

  Won, You Jin ^a   Yoo, Jong Yoon ^a   Lee, Jong Hwan ^b   Hwang, Seung Jun ^a   Kim, Donghou ^a   Hong, Hea Nam ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Erythropoietin; GABAergic neurons; Glutamate decarboxylase 67; Janus kinase 2; Kainic acid; Spinal cord

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GLUTAMATE DECARBOXYLASE 67; JANUS KINASE 2; KAINIC ACID;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL LYSATE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENERGY METABOLISM; EXCITOTOXICITY; IMMUNOHISTOCHEMISTRY; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; CELL COUNT; CELLS, CULTURED; DRUG INTERACTIONS; ERYTHROPOIETIN; EXCITATORY AMINO ACID AGONISTS; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION; GLUTAMATE DECARBOXYLASE; ISOENZYMES; JANUS KINASE 2; KAINIC ACID; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ERYTHROPOIETIN; SPINAL CORD;

RATTUS;

EID: 34249781673     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.04.010     Document Type: Article

References (31)

1. 2+-permeable AMPA receptors. Eur. J. Neurosci. 11 (1999) 2758-2766
2. A receptor in the mammalian spinal cord. J. Comp. Neurol. 365 (1996) 392-412
3. Behar T., Schaffner A., Laing P., Hudson L., Komoly S., and Barker J.L. Many spinal cord cells transiently express low molecular weight forms of glutamic acid decarboxylase during embryonic development. Brain Res. 72 (1993) 203-218
4. Bernaudin M., Marti H.H., Roussel S., Divoux D., Nouvelot A., MacKenzie E.T., and Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb Blood Flow Metab. 19 (1999) 643-651
5. Celik M., Gokmen N., Erbayraktar S., Akhisaroglu M., Konakc S., Ulukus C., Genc S., Genc K., Sagiroglu E., Cerami A., and Brines M. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2258-2263
6. Cherubini E., Gaiarsa J.L., and Ben-Ari Y. GABA: an excitatory transmitter in early postnatal life. TINS 14 (1991) 515-519
7. Digicaylioglu M., and Lipton S.A. Erythropoietin mediated neuroprotection involves cross-talk between Jak2 and NF-κB signaling cascades. Nature 412 (2001) 641-647
8. Erlander M.G., Tillakaratne N.J.K., Feldblum S., Patel N., and Tobin A.J. Two genes encode distinct glutamate decarboxylases. Neuron 7 (1991) 91-100
9. Esclapez M., Tillakaratne N.J.K., Kaufman D.L., Tobin A.J., and Houser C.R. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J. Neurosci. 14 (1994) 1834-1855
10. Faden A.I., and Simon R.P. A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann. Neurol. 23 (1998) 623-626
11. Feldblum S., Dumoulin A., Anoal M., Sandillon F., and Privat A. Comparative distribution of GAD65 and GAD67 mRNAs and proteins in the rat spinal cord supports a differential regulation of these two glutamate decarboxylases in vivo. J. Neurosci. Res. 42 (1995) 742-757
12. Feldblum S., Anoal M., Lapsher S., Dumoulin A., and Privat A. Partial deafferentation of the developing rat spinal cord delays the spontaneous repression of GAD67 mRNAs in spinal cells. Perspect. Dev. Neurobiol. 5 (1998) 131-143
13. Gallo V., Suergiu R., and Levi G. Kainic acid stimulates GABA release from a subpopulation of cerebellar astrocytes. Eur. J. Pharmacol. 133 (1986) 319-322
14. Gorio A., Gokmen N., Erbayraktar S., Yilmaz O., Madaschi L., Cichetti C., Di Giulio A.M., Vardar E., Cerami A., and Brines M. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 9450-9455
15. Hugon J., Vallat JM., Spencer P.S., Leboutet M.J., and Barthe D. Kainic acid induces early and delayed degenerative neuronal changes in rat spinal cord. Neurosci. Lett. 104 (1989) 258-262
16. Jow F., Chiu D., Lim H.K., Novak T., and Lin S. Production of GABA by cultured hippocampal glial cells. Neurochem. Int. 45 (2004) 273-283
17. Kaufman D.L., Houser C.R., and Tobin A.J. Two forms of the gammaaminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J. Neurochem. 56 (1991) 720-723
18. Kretz A., Happold C.J., Marticke J.K., and Isenmann S. Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation. Mol. Cell. Neurosci. 29 (2005) 569-579
19. Layton C.J., Wood J.P., Chidlow G., and Osborne N.N. Neuronal death in primary retinal cultures is related to nitric oxide production, and is inhibited by erythropoietin in a glucose-sensitive manner. J. Neurochem. 92 (2005) 487-493
20. Mackie M., Hughes D.I., Maxwell D.J., Tillakaratne N.J., and Todd A.J. Distribution and colocalisation of glutamate decarboxylase isoforms in the rat spinal cord. Neurosci. 119 (2003) 461-472
21. Morishita E., Masuda S., Nagao M., Yasuda Y., and Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neurosci. 76 (1997) 105-116
22. Rothstein J.D., Jin L., Dykes-Hoberg M., and Kuncl R.W. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 6591-6595
23. Ruscher K., Freyer D., Karsch M., Isaev N., Megow D., Sawitzki B., Priller J., Dirnagl U., and Meisel A. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 22 (2002) 10291-10301
24. Sadamoto Y., Igase K., Sakanaka M., Sato K., Otsuka H., Sakaki S., Masuda S., and Sasaki R. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem. Biophys. Res. Commun. 253 (1998) 26-32
25. Sakanaka M., Wen T.C., Matsuda S., Masuda S., Morishita E., Nagao M., and Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 4635-4640
26. Scheid M.P., and Woodgett J.R. PKB/AKT: functional insights from genetic models. Nat. Rev., Mol. Cell Biol. 2 (2001) 760-768
27. Siren A.L., Knerlich F., Poser W., Gleiter C.H., Bruck W., and Ehrenreich H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol. (Berl) 101 (2001) 271-276
28. Tillakaratne N.J., Mouria M., Ziv N.B., Roy R.R., Edgerton V.R., and Tobin A.J. Increased expression of glutamate decarboxylase (GAD(67)) in feline lumbar spinal cord after complete thoracic spinal cord transection. J. Neurosci. Res. 60 (2000) 219-230
29. Witthuhn B.A., Quelle F.W., Silvennoinen O., Yi T., Tang B., Miura O., and Ihle J.N. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74 (1993) 227-236
30. Wu W.L., Ziskind-Conhaim L., and Sweet M.A. Early development of glycine- and GABA-mediated synapses in rat spinal cord. J. Neurosci. 12 (1992) 3935-3945
31. Yin H.Z., Park D.D., Lindsay A.D., and Weiss J.H. Spinal cord neurons are vulnerable to rapidly triggered kainate neurotoxicity in vitro. Brain Res. 689 (1995) 265-270